Growth Hormone Therapy Is Safe and Effective in Patients with Lysinuric Protein Intolerance

Background: Lysinuric protein intolerance (LPI) is an autosomal recessive cationic amino acid transport defect characterized by episodes of postprandial hyperammonemias and spontaneous protein aversion. Subnormal growth is common in spite of appropriate nutritional therapy. Growth hormone (GH) thera...

Celý popis

Uloženo v:
Podrobná bibliografie
Hlavní autoři: Niinikoski, Harri, Lapatto, Risto, Nuutinen, Matti, Tanner, Laura, Simell, Olli, Näntö-Salonen, Kirsti
Médium: Artigo
Jazyk:Inglês
Vydáno: Springer Berlin Heidelberg 2011
Témata:
Article
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC3509816/
https://ncbi.nlm.nih.gov/pubmed/23430827
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/8904_2011_15
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky